Cargando…

Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the most prevalent cause of chronic liver disease worldwide. Type 2 diabetes mellitus (T2DM) is a risk factor that accelerates NAFLD progression, leading to fibrosis and cirrhosis. Thus, here we aimed to develop a simple model to predict the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jiwon, Lee, Minyoung, Kim, Soo Yeon, Kim, Ji-Hye, Nam, Ji Sun, Chun, Sung Wan, Park, Se Eun, Kim, Kwang Joon, Lee, Yong-ho, Nam, Joo Young, Kang, Eun Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419619/
https://www.ncbi.nlm.nih.gov/pubmed/34474517
http://dx.doi.org/10.3803/EnM.2021.1074
_version_ 1783748790697590784
author Kim, Jiwon
Lee, Minyoung
Kim, Soo Yeon
Kim, Ji-Hye
Nam, Ji Sun
Chun, Sung Wan
Park, Se Eun
Kim, Kwang Joon
Lee, Yong-ho
Nam, Joo Young
Kang, Eun Seok
author_facet Kim, Jiwon
Lee, Minyoung
Kim, Soo Yeon
Kim, Ji-Hye
Nam, Ji Sun
Chun, Sung Wan
Park, Se Eun
Kim, Kwang Joon
Lee, Yong-ho
Nam, Joo Young
Kang, Eun Seok
author_sort Kim, Jiwon
collection PubMed
description BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the most prevalent cause of chronic liver disease worldwide. Type 2 diabetes mellitus (T2DM) is a risk factor that accelerates NAFLD progression, leading to fibrosis and cirrhosis. Thus, here we aimed to develop a simple model to predict the presence of NAFLD based on clinical parameters of patients with T2DM. METHODS: A total of 698 patients with T2DM who visited five medical centers were included. NAFLD was evaluated using transient elastography. Univariate logistic regression analyses were performed to identify potential contributors to NAFLD, followed by multivariable logistic regression analyses to create the final prediction model for NAFLD. RESULTS: Two NAFLD prediction models were developed, with and without serum biomarker use. The non-laboratory model comprised six variables: age, sex, waist circumference, body mass index (BMI), dyslipidemia, and smoking status. For a cutoff value of ≥60, the prediction accuracy was 0.780 (95% confidence interval [CI], 0.743 to 0.817). The second comprehensive model showed an improved discrimination ability of up to 0.815 (95% CI, 0.782 to 0.847) and comprised seven variables: age, sex, waist circumference, BMI, glycated hemoglobin, triglyceride, and alanine aminotransferase to aspartate aminotransferase ratio. Our non-laboratory model showed non-inferiority in the prediction of NAFLD versus previously established models, including serum parameters. CONCLUSION: The new models are simple and user-friendly screening methods that can identify individuals with T2DM who are at high-risk for NAFLD. Additional studies are warranted to validate these new models as useful predictive tools for NAFLD in clinical practice.
format Online
Article
Text
id pubmed-8419619
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-84196192021-09-14 Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts Kim, Jiwon Lee, Minyoung Kim, Soo Yeon Kim, Ji-Hye Nam, Ji Sun Chun, Sung Wan Park, Se Eun Kim, Kwang Joon Lee, Yong-ho Nam, Joo Young Kang, Eun Seok Endocrinol Metab (Seoul) Original Article BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the most prevalent cause of chronic liver disease worldwide. Type 2 diabetes mellitus (T2DM) is a risk factor that accelerates NAFLD progression, leading to fibrosis and cirrhosis. Thus, here we aimed to develop a simple model to predict the presence of NAFLD based on clinical parameters of patients with T2DM. METHODS: A total of 698 patients with T2DM who visited five medical centers were included. NAFLD was evaluated using transient elastography. Univariate logistic regression analyses were performed to identify potential contributors to NAFLD, followed by multivariable logistic regression analyses to create the final prediction model for NAFLD. RESULTS: Two NAFLD prediction models were developed, with and without serum biomarker use. The non-laboratory model comprised six variables: age, sex, waist circumference, body mass index (BMI), dyslipidemia, and smoking status. For a cutoff value of ≥60, the prediction accuracy was 0.780 (95% confidence interval [CI], 0.743 to 0.817). The second comprehensive model showed an improved discrimination ability of up to 0.815 (95% CI, 0.782 to 0.847) and comprised seven variables: age, sex, waist circumference, BMI, glycated hemoglobin, triglyceride, and alanine aminotransferase to aspartate aminotransferase ratio. Our non-laboratory model showed non-inferiority in the prediction of NAFLD versus previously established models, including serum parameters. CONCLUSION: The new models are simple and user-friendly screening methods that can identify individuals with T2DM who are at high-risk for NAFLD. Additional studies are warranted to validate these new models as useful predictive tools for NAFLD in clinical practice. Korean Endocrine Society 2021-08 2021-08-27 /pmc/articles/PMC8419619/ /pubmed/34474517 http://dx.doi.org/10.3803/EnM.2021.1074 Text en Copyright © 2021 Korean Endocrine Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Jiwon
Lee, Minyoung
Kim, Soo Yeon
Kim, Ji-Hye
Nam, Ji Sun
Chun, Sung Wan
Park, Se Eun
Kim, Kwang Joon
Lee, Yong-ho
Nam, Joo Young
Kang, Eun Seok
Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
title Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
title_full Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
title_fullStr Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
title_full_unstemmed Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
title_short Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
title_sort non-laboratory-based simple screening model for nonalcoholic fatty liver disease in patients with type 2 diabetes developed using multi-center cohorts
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419619/
https://www.ncbi.nlm.nih.gov/pubmed/34474517
http://dx.doi.org/10.3803/EnM.2021.1074
work_keys_str_mv AT kimjiwon nonlaboratorybasedsimplescreeningmodelfornonalcoholicfattyliverdiseaseinpatientswithtype2diabetesdevelopedusingmulticentercohorts
AT leeminyoung nonlaboratorybasedsimplescreeningmodelfornonalcoholicfattyliverdiseaseinpatientswithtype2diabetesdevelopedusingmulticentercohorts
AT kimsooyeon nonlaboratorybasedsimplescreeningmodelfornonalcoholicfattyliverdiseaseinpatientswithtype2diabetesdevelopedusingmulticentercohorts
AT kimjihye nonlaboratorybasedsimplescreeningmodelfornonalcoholicfattyliverdiseaseinpatientswithtype2diabetesdevelopedusingmulticentercohorts
AT namjisun nonlaboratorybasedsimplescreeningmodelfornonalcoholicfattyliverdiseaseinpatientswithtype2diabetesdevelopedusingmulticentercohorts
AT chunsungwan nonlaboratorybasedsimplescreeningmodelfornonalcoholicfattyliverdiseaseinpatientswithtype2diabetesdevelopedusingmulticentercohorts
AT parkseeun nonlaboratorybasedsimplescreeningmodelfornonalcoholicfattyliverdiseaseinpatientswithtype2diabetesdevelopedusingmulticentercohorts
AT kimkwangjoon nonlaboratorybasedsimplescreeningmodelfornonalcoholicfattyliverdiseaseinpatientswithtype2diabetesdevelopedusingmulticentercohorts
AT leeyongho nonlaboratorybasedsimplescreeningmodelfornonalcoholicfattyliverdiseaseinpatientswithtype2diabetesdevelopedusingmulticentercohorts
AT namjooyoung nonlaboratorybasedsimplescreeningmodelfornonalcoholicfattyliverdiseaseinpatientswithtype2diabetesdevelopedusingmulticentercohorts
AT kangeunseok nonlaboratorybasedsimplescreeningmodelfornonalcoholicfattyliverdiseaseinpatientswithtype2diabetesdevelopedusingmulticentercohorts